drugset / Trial / NCT02007512
Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine if enzalutamide given in combination with exemestane is safe and effective in patients with advanced breast cancer.
Timeline
- Start
- 2013-12-16
- Primary completion
- 2016-09-23
- Completion
- 2024-08-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enzalutamide | Other / unclassified | 160 mg | Oral |
| Subject | Exemestane | Small molecule | 25 mg | Oral |
| Subject | Exemestane | Small molecule | 50 mg | Oral |